Bausch Health Gains 2.6% as EPS Estimate Rises 0.4% to $1.21
Bausch Health shares rose 2.6% to close at $5.88 after a month-long 26.3% decline. Consensus EPS estimate for the upcoming quarter ticked up 0.4% to $1.21, representing a 5.2% year-over-year increase, and the stock holds a Zacks Rank #2 Buy rating.
1. Stock Performance
Bausch Health shares gained 2.6% to $5.88 in the latest session, partially retracing a 26.3% drop over the past month as investors reassessed the company’s outlook.
2. Earnings Outlook
Analysts boosted the upcoming quarterly EPS forecast by 0.4% to $1.21, marking a 5.2% year-over-year increase, and the stock maintains a Zacks Rank #2 Buy recommendation.
Related News
AMZN
Amazon MGM Invests $75M in Melania Documentary Despite Political Scrutiny
AMZN•
GOOGL
Alphabet Executes Record Yen Bond Sale as Google Secures 9.7 GWh AI Storage Contracts
GOOGL•
GS
Oil Prices Rebound to $99–$106 After Trump Iran Deal Comments, Inventories Drop
GS•
KDP
Keurig Dr Pepper Sets $0.23 Dividend, CEO to Present at June 3 Conference
KDP•
CRM
Salesforce Faces Competition from Nvidia’s $200B AI CPU, Nasdaq Rally
CRM•
Sources
F